Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
80%
Thromboxane Synthase Inhibitor
61%
Dabigatran
58%
Rivaroxaban
57%
Thromboxane
57%
Thromboxane A2
48%
Thromboxane Receptor
45%
Drug
45%
Dabigatran Etexilate
43%
Antivitamin K
42%
Direct Oral Anticoagulant
41%
Bleeding
41%
Thromboxane Receptor Blocking Agent
40%
Diseases
39%
Nanomaterial
39%
Urea
38%
Protein Tyrosine Kinase Inhibitor
37%
Arachidonic Acid
34%
Malignant Neoplasm
33%
Thromboembolism
30%
Carbonate Dehydratase
30%
Atherosclerosis
30%
Atrial Fibrillation
29%
Inflammation
28%
Heparin
28%
Mouse
28%
X-Ray
27%
Thromboxane Synthase
26%
Rat
26%
Chronic Myeloid Leukemia
25%
Thromboxane A2 Receptor Blocking Agent
25%
Thrombin
24%
Nanoparticle
24%
Toxicity
23%
Prostacyclin
23%
Thromboplastin
23%
Paroxysmal Nocturnal Hemoglobinuria
22%
Prospective Study
22%
Pharmacokinetics
22%
Apixaban
21%
Ponatinib
21%
Silicon Carbide
20%
Clinical Study
20%
Nilotinib
19%
Dasatinib
19%
Carbonate Dehydratase IX
18%
Thrombosis
18%
Artery Thrombosis
18%
Heart Infarction
18%
Sulfonamide
18%
Medicine and Dentistry
Assay
100%
Patient
75%
Severe Acute Respiratory Syndrome Coronavirus 2
68%
Neutralizing Antibody
60%
COVID-19
60%
Laboratory
47%
Vaccine
47%
Therapeutic Procedure
46%
Plasma
42%
Assessment
41%
Diagnosis
41%
Antibody
39%
Thrombosis
38%
Infection
38%
Thrombin
35%
Cells
34%
Coagulation
34%
Activated Protein C Resistance
32%
Woman
30%
Antigen
28%
Blood Stasis
26%
Procoagulant
26%
Inpatient
26%
In Vitro
25%
COVID-19 Vaccination
24%
Platelet
23%
Immunoglobulin G
22%
Endothelial Cell
20%
Protein
20%
Combination Therapy
19%
Antibody Response
19%
Blood
19%
Thrombocyte Aggregation
19%
Heparin
18%
Humoral Immunity
18%
Atherosclerosis
17%
Thromboplastin
17%
Syndrome
17%
Thrombocytopenia
17%
Heparin-Induced Thrombocytopenia
16%
Virus
16%
Betrixaban
16%
Rivaroxaban
16%
Acute Leukemia
15%
Atherogenesis
15%
Masking
15%
Membrane Microparticle
15%
Tyrosine-Kinase Inhibitor
15%
Cell Survival
15%
Cell Function
15%
Biochemistry, Genetics and Molecular Biology
Coagulation
61%
Thrombin
50%
Sample
44%
Hemostasis
40%
SARS Coronavirus
36%
Thrombocyte Aggregation
31%
Blood Level
28%
Synthesis
24%
Time
23%
Taxonomy
22%
Antibody
22%
Thromboxane
22%
Thromboxane A2
22%
Anticoagulation
19%
Dose
19%
Rivaroxaban
19%
Light
18%
Platelet
17%
Partial Thromboplastin Time
17%
Synthase
16%
Urea
16%
Rat Model
16%
Thrombin Time
16%
Thrombocyte Function
15%
Immunoglobulin M
15%
Tyrosine Kinase Inhibitor
15%
Kinetics
14%
Laboratory Test
13%
Reverse Transcription Polymerase Chain Reaction
13%
Prothrombin Time
13%
D-Dimer
12%
Vitamin K
11%
Protein
11%
Molecule
11%
Virus Load
11%
Impedance
10%
Receptor Antagonist
10%
Coronavirinae
10%
Aptitude
10%
Mouse
10%
Isoform
10%
Tissue Factor Pathway Inhibitor
10%
Coagulation System
10%
Protease
10%
Development
9%
Myeloid
9%
IC50
9%
Immune Response
9%
Structure Activity Relation
9%
Thromboxane Receptor
9%
